pS2 protein in breast carcinomas: Cut-off value of estrogen-regulated expression

Neoplasma

Volumn 48, Issue 1, 2001, Pages 1-6

  Nikolic Vukosavljevic D ^a   Grujic Adanja G ^a   Jankovic R ^a   Neskovic Konstantinovic Z ^a   Brankovic Magic M ^a   Mitrovic L ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

Breast carcinoma; Clinico pathological features; pS2 cut off value; SR

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; PROGESTERONE; PROGESTERONE RECEPTOR; PROTEIN PS2; STEROID; STEROID RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; CANCER GRADING; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PROTEIN EXPRESSION;

EID: 0035117533     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Histological grading of breast cancer
2. Revision of the standards for the assessment of receptors in human breast cancer
3. Relationship of pS2 with respect to tamoxifen therapy in patients with recurrent breast cancer
4. Prediction of relapse and survival in breast cancer patients by pS2 protein satus
5. Prognostic value of pS2 and Cathepsin D in 710 human primary breast tumors: Multivariate analysis
6. pS2 in breast cancer-alternative or complementary tool to steroid receptor stats? Evaluation of 446 cases
7. Immunoradiometric assay of pS2 protein in breast cancer cytosols
8. PNR-2/pS2 immunohistochemical staining and endocrine response
9. Expression of pS2 protein and estrogen and progesterone receptor status in breast cancer
10. pS2 protein and steroid hormone receptors in invasive breast carcinomas
11. Immunoradiometric detection of pS2 and total cathepsin D in primary breast biopsies: Their correlation with steroid receptors
12. Cloning of cDNA sequences of hormone-regulated genes from MCF-7 human breast cancer cell line
13. Trefoil proteins: Their role in normal and malignant cells
14. Steroid hormone receptors and carcinoma of the breast
15. Standardization of steroid hormone receptor assay
16. Estrogen dependence of primary breast cancer - Correlation with histologic type and grade
17. pS2 in breast carcinoma: Association with steroid hormone receptor status
18. The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumor promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein
19. Enzyme-linked immunosorbent assay of pS2 in breast cancers, benign tumors and normal breast tissues
20. Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of estrogen and progesterone receptors and the oncogene ERBB2
21. On behalf of the EORTC Receptor Study Group: Steroid receptor distribution in 47 892 breast cancer. A collaborative study of 7 European Laboratories
22. Histological typing of breast tumors
23. pS2 expression and response to hormonal therapy in patients with advance breast cancer
24. pS2 protein: A marker improving prediction of response to neoadjuvant tamoxifen in postmenopausal breast cancer patients
25. Immunohistochemical determination of pS2 in invasive breast carcinomas. A study on 942 cases
26. Adjuvant tamoxifen therapy of dependence of receptor level
27. Steroid receptors, pS2 and Cathepsin D in early clinically node-negative breast cancer
28. pS2 expression in primary breast carcinomas: Relationships to clinical and histological features and survival